Man Hong Tam
Directeur Financier/CFO chez QuantumPharm, Inc.
Profil
Man Hong Tam is currently the Chief Financial Officer & Joint Secretary at QuantumPharm, Inc. since 2023.
He is also a Member of the Hong Kong Institute of Certified Public Accountants since 2003.
Previously, he held positions such as Managing Director at UBS AG from 2018 to 2020, Director at UBS AG (Hong Kong Branch) from 2007 to 2011, Managing Director at Jefferies Hong Kong Ltd.
from 2011 to 2015, Managing Director at Guosen Securities (HK) Financial Holdings Co., Ltd.
from 2016 to 2017, Managing Director at BOSC International Co. Ltd.
from 2017 to 2018, and Chief Financial Officer at HUYA Bioscience International LLC in 2020.
He obtained a graduate degree from the University of Cambridge in 2020 and an undergraduate degree from Auckland University in 1997.
Postes actifs de Man Hong Tam
| Sociétés | Poste | Début |
|---|---|---|
QuantumPharm, Inc.
 QuantumPharm, Inc. BiotechnologyHealth Technology QuantumPharm, Inc. operates as a holding company with interests in drug research and development services. It engages in the business relating to drug discovery solutions including one-stop drug discovery solutions and automated chemical synthesis services and intelligent automation services. The company was founded by Lai Li Ppeng, Ma Jian and Wen Shu Hao in 2015 and is headquartered in Shenzhen, China. | Directeur Financier/CFO | 01/12/2020 |
Hong Kong Institute of Certified Public Accountants
 Hong Kong Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Hong Kong Institute of Certified Public Accountants operates under the professional accountant’s ordinance and works in the public interest. It offers CPA qualification programme and promulgating financial reporting, auditing and ethical standards in Hong Kong. The company was founded on January 1, 1973 and is headquartered in Hong Kong. | Corporate Officer/Principal | 01/01/2003 |
Anciens postes connus de Man Hong Tam
| Sociétés | Poste | Fin |
|---|---|---|
HUYA Bioscience International LLC
 HUYA Bioscience International LLC Pharmaceuticals: MajorHealth Technology HUYA Bioscience International LLC develops biopharmaceutical products. It sources pharmaceutical innovation originating in China for global development in international markets. It's lead immune-oncology lead product, HBI-8000, already approved in China, is now in registration trials in Japan and Korea for lymphoma and in clinical trials in the U.S. for various solid tumor indications in combination with the checkpoint inhibitor nivolumab. The company was founded by Mireille Gillings in 2004 and is headquartered in San Diego, CA. | Directeur Financier/CFO | 01/11/2020 |
| UBS | Directeur Général | 01/07/2020 |
BOSC International Co. Ltd.
 BOSC International Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Bank of Shanghai Co., Ltd., BOSC International Co. Ltd. provides financial consulting services. The company is based in Hong Kong, Hong Kong. The CEO of the Chinese company is Chi Wah Lau. | Directeur Général | 01/05/2018 |
| Guosen Securities (HK) Financial Holdings Co., Ltd. | Directeur Général | 01/01/2017 |
Jefferies Hong Kong Ltd.
 Jefferies Hong Kong Ltd. Investment Banks/BrokersFinance Jefferies Hong Kong Ltd. is a securities brokerage firm headquartered in Hong Kong. The firm is a subsidiary of Jefferies Group LLC, which is owned by Jefferies Financial Group, Inc. (NYSE: JEF) in the US. Jefferies Hong Kong is a client-focused full-service sales, trading and capital markets platform across all equity and fixed income securities. They provide an array of trading and execution services for their clients. | Directeur Général | 01/11/2015 |
Formation de Man Hong Tam
| University of Cambridge | Graduate Degree |
| Auckland University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
 | Health Technology |
| Entreprise privées | 7 |
|---|---|
UBS AG
 UBS AG Investment ManagersFinance UBS AG engages in the provision of financial advisory solutions for private and institutional investors, intermediaries, and wealth management clients. The firm focuses on the areas of wealth and asset management, as well as investment banking. It offers retail investment products, global financing services, investment research, bespoke financing, traditional investments, as well as bonds and equities. The company was founded in 1862 and is headquartered in Zurich, Switzerland. | Finance |
HUYA Bioscience International LLC
HUYA Bioscience International LLC Pharmaceuticals: MajorHealth Technology HUYA Bioscience International LLC develops biopharmaceutical products. It sources pharmaceutical innovation originating in China for global development in international markets. It's lead immune-oncology lead product, HBI-8000, already approved in China, is now in registration trials in Japan and Korea for lymphoma and in clinical trials in the U.S. for various solid tumor indications in combination with the checkpoint inhibitor nivolumab. The company was founded by Mireille Gillings in 2004 and is headquartered in San Diego, CA. | Health Technology |
UBS AG (Hong Kong Branch)
 UBS AG (Hong Kong Branch) Investment Banks/BrokersFinance Part of UBS Group AG, UBS AG (Hong Kong Branch) is a Chinese company that provides investment banking securities dealing services. The company is based in Hong Kong, Hong Kong. | Finance |
Hong Kong Institute of Certified Public Accountants
Hong Kong Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Hong Kong Institute of Certified Public Accountants operates under the professional accountant’s ordinance and works in the public interest. It offers CPA qualification programme and promulgating financial reporting, auditing and ethical standards in Hong Kong. The company was founded on January 1, 1973 and is headquartered in Hong Kong. | Commercial Services |
Jefferies Hong Kong Ltd.
Jefferies Hong Kong Ltd. Investment Banks/BrokersFinance Jefferies Hong Kong Ltd. is a securities brokerage firm headquartered in Hong Kong. The firm is a subsidiary of Jefferies Group LLC, which is owned by Jefferies Financial Group, Inc. (NYSE: JEF) in the US. Jefferies Hong Kong is a client-focused full-service sales, trading and capital markets platform across all equity and fixed income securities. They provide an array of trading and execution services for their clients. | Finance |
| Guosen Securities (HK) Financial Holdings Co., Ltd. | |
BOSC International Co. Ltd.
BOSC International Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Bank of Shanghai Co., Ltd., BOSC International Co. Ltd. provides financial consulting services. The company is based in Hong Kong, Hong Kong. The CEO of the Chinese company is Chi Wah Lau. | Commercial Services |
